A More Reliable Diagnosis Of Neuroendocrine Tumors
A new assay method has been developed to measure chromogranin A in peripheral blood, allowing clinicians to follow the outcome of gastrointestinal neuroendocrine tumors. This method could also serve as a diagnostic marker for other types of neuroendocrine tumor, such as small-cell lung cancer in smokers.
SourceFrench National Institute for Health and Medical Research (INSERM)·JournalBritish Journal of Cancer·DateDec 12, 1998